CoChat

Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021

Open access
Zhou, Jinlei, Zhang, Yuan, He, Shuangshuang, Xu, Sen, Sun, Qice, Zhao, Tingxiao, Dai, Yaqin · 2025 · Scientific Reports

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

A thorough and current analysis of the burden and evolving trends in depressive disorders during the COVID-19 pandemic from 2019 to 2021 remains unavailable. Employing the Global Burden of Disease (GBD) 2021 database, we evaluated the burden of depressive disorders at the global, regional, and national levels, stratifying the analysis by age, gender, and socio-demographic index (SDI). To examine trends in depressive disorders during the epidemic, we calculated the estimated annual percentage change (EAPC) in age-standardized incidence rates (ASIR), age-standardized prevalence rates (ASPR), and age-standardized DALYs rates (ASDR) across all levels from 2019 to 2021. Furthermore, we performed a frontier analysis of depressive disorders across various countries, incorporating risk factor analyses at multiple levels. In 2021, the global incidence of depressive disorders stood at 357.43 million, while the prevalence was recorded at 332.41 million, accompanied by 56.33 million disability-adjusted life years (DALYs). Throughout the COVID-19 pandemic, there was a notable upward trend in ASIR (EAPC = 8.33 [-0.46 to 17.9]), ASPR (EAPC = 6.02 [0.28 to 12.09]), and ASDR (EAPC = 7.13 [-0.18 to 14.97]) for depressive disorders on a global scale. The burden of depressive disorders is most pronounced among females and individuals aged 60 to 64 within their respective subgroups. From 1990 to 2021, the burden of depressive disorders consistently remained highest in the low SDI region; however, it experienced the most significant increase in the high SDI region during the COVID-19 pandemic from 2019 to 2021. In 2021, the burden of depressive disorders was highest in central sub-Saharan Africa, Greenland, and Uganda, while the Andean region of Latin America, along with Bulgaria and Belarus, experienced the most significant increase in depressive disorders during the COVID-19 pandemic. Globally, bullying victimization, intimate partner violence, and childhood sexual abuse contributed to 6.47%, 4.91%, and 2.65% of the ASDR for depressive disorders, respectively. The global burden of depressive disorders has markedly increased during the COVID-19 pandemic, gradually shifting from low to high SDI regions, particularly in North America and Europe.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-025-93923-4

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The number of incidences, prevalence, DALYs, and ASRs for depressive disorder at the global and gender levels from 1990 to 2021. (A) global; (B) gender (ASRs); (C) gender (incidences, prevalence and DALYs).
Fig. 1 The number of incidences, prevalence, DALYs, and ASRs for depressive disorder at the global and gender levels from 1990 to 2021. (A) global; (B) gender (ASRs); (C) gender (incidences, prevalence and DALYs).CC BY-NC-ND · PubMed Central
Fig. 2 The number of incidences, prevalence, DALYs, and ASRs for depressive disorder at the age and SDI level from 1990 to 2021. (A) age (ASRs); (B) age (incidences, prevalence and DALYs); (C) SDI (ASRs); (D) SDI (incidences, prevalence and DALYs).
Fig. 2 The number of incidences, prevalence, DALYs, and ASRs for depressive disorder at the age and SDI level from 1990 to 2021. (A) age (ASRs); (B) age (incidences, prevalence and DALYs); (C) SDI (ASRs); (D) SDI (incidences, prevalence and DALYs).CC BY-NC-ND · PubMed Central
Fig. 3 The number of incidences, prevalence, DALYs, ASRs, and EAPC for depressive disorder in 204 countries and regions from 2019 to 2021. (A) ASIR in 2021; (B) ASPR in 2021; (C) ASDR in 2021; (D) incidences in 2021; (E) prevalences in 2021; (F) DALYs in 2021; (G) EAPC for ASIR from 2019 to 2021; (H) EAPC for ASPR from 2019 to 2021; (I) EAPC for ASDR from 2019 to 2021.
Fig. 3 The number of incidences, prevalence, DALYs, ASRs, and EAPC for depressive disorder in 204 countries and regions from 2019 to 2021. (A) ASIR in 2021; (B) ASPR in 2021; (C) ASDR in 2021; (D) incidences in 2021; (E) prevalences in 2021; (F) DALYs in 2021; (G) EAPC for ASIR from 2019 to 2021; (H) EAPC for ASPR from 2019 to 2021; (I) EAPC for ASDR from 2019 to 2021.CC BY-NC-ND · PubMed Central
Fig. 4 Frontier analysis of ASIR, ASPR and ASDR in depressive disorder in 2021. (A) ASIR; (B) ASPR; (C) ASDR.
Fig. 4 Frontier analysis of ASIR, ASPR and ASDR in depressive disorder in 2021. (A) ASIR; (B) ASPR; (C) ASDR.CC BY-NC-ND · PubMed Central
Fig. 5 The extent to which the three risk factors influence ASDR for depressive disorder at the global, regional, age, and gender levels.
Fig. 5 The extent to which the three risk factors influence ASDR for depressive disorder at the global, regional, age, and gender levels.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 1

  1. McEwen, B. S. & Alves, S. E. Estrogen actions in the central nervous system [J]. Endocr. Rev. 20(3), 279–307 (1999).

Cited by

See all 26

Metadata

Authors
Zhou, J., Zhang, Y., He, S., Xu, S., Sun, Q., Zhao, T., & Dai, Y.
Affiliations
  • Zhejiang Provincial People's Hospital (CN)
  • Zhejiang Chinese Medical University (CN)
Corresponding author
  • Zhao, Tingxiao
  • Dai, Yaqin
Venue
Scientific Reports
Published
2025-03-19
Volume
15
Issue
1
Pages
9529-9529
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4408611311
Cited by
20
References
38
Citations by year
2026: 12 · 2025: 8
FWCI
23.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
depressive disorders, COVID-19 pandemic, global burden of disease, disability-adjusted life years, incidence and prevalence trends, socio-demographic index, sex differences, age differences, bullying victimization, intimate partner violence, child sexual abuse, risk factors, mental health burden, sub-Saharan Africa, Latin America, Eastern Europe, Pacific Islands, Middle East and North Africa, South Asia, North America
MeSH terms
Global Burden of Disease, COVID-19, SARS-CoV-2, Disability-Adjusted Life Years, Adolescent, Adult, Aged, Depressive Disorder, Female, Humans, Male, Middle Aged, Risk Factors, Global Health, Incidence, Prevalence, Cost of Illness, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021. https://app.cochat.ai/papers/10.1038/s41598-025-93923-4
The paper
Zhou, J., Zhang, Y., He, S., Xu, S., Sun, Q., Zhao, T., & Dai, Y. (2025). Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021. Scientific Reports. https://doi.org/10.1038/s41598-025-93923-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.